Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04162210
Title Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
Acronym DREAMM-3
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
GSK Investigational Site Tucson Arizona 85715 United States Details
GSK Investigational Site Pueblo Colorado 81008 United States Details
GSK Investigational Site Detroit Michigan 48202 United States Details
GSK Investigational Site Omaha Nebraska 68130 United States Details
GSK Investigational Site Albany New York 12208-3479 United States Details
GSK Investigational Site Cincinnati Ohio 45236 United States Details
GSK Investigational Site Eugene Oregon 97401 United States Details
GSK Investigational Site Salem Oregon 97301 United States Details
GSK Investigational Site Tyler Texas 75702 United States Details
GSK Investigational Site Milwaukee Wisconsin 53226 United States Details
GSK Investigational Site Gosford New South Wales 2250 Australia Details
GSK Investigational Site Liverpool New South Wales 2170 Australia Details
GSK Investigational Site St Leonards New South Wales 2065 Australia Details
GSK Investigational Site Woodville South Australia 5011 Australia Details
GSK Investigational Site Hobart Tasmania 7000 Australia Details
GSK Investigational Site Clayton Victoria 3168 Australia Details
GSK Investigational Site Fitzroy Victoria 3065 Australia Details
GSK Investigational Site Geelong Victoria 3220 Australia Details
GSK Investigational Site Nedlands Western Australia 6009 Australia Details
GSK Investigational Site St. Albans 03021 Australia Details
GSK Investigational Site Brugge 8000 Belgium Details
GSK Investigational Site Bruxelles 1200 Belgium Details
GSK Investigational Site Edegem 2650 Belgium Details
GSK Investigational Site Jette 1090 Belgium Details
GSK Investigational Site Kortrijk 8500 Belgium Details
GSK Investigational Site Yvoir 5530 Belgium Details
GSK Investigational Site Fortaleza Ceará 60115-281 Brazil Details
GSK Investigational Site Curitiba Paraná 03089-070 Brazil Details
GSK Investigational Site Porto Alegre Rio Grande Do Sul 90035-903 Brazil Details
GSK Investigational Site Porto Alegre Rio Grande Do Sul 90110-270 Brazil Details
GSK Investigational Site Rio de Janeiro 21941-913 Brazil Details
GSK Investigational Site Rio de Janeiro 22793-080 Brazil Details
GSK Investigational Site São Paulo 01321001 Brazil Details
GSK Investigational Site São Paulo 01509-900 Brazil Details
GSK Investigational Site São Paulo 04537-080 Brazil Details
GSK Investigational Site São Paulo 05651-901 Brazil Details
GSK Investigational Site Pleven 5800 Bulgaria Details
GSK Investigational Site Plovdiv 4000 Bulgaria Details
GSK Investigational Site Sofia 01431 Bulgaria Details
GSK Investigational Site Sofia 1000 Bulgaria Details
GSK Investigational Site Sofia 1407 Bulgaria Details
GSK Investigational Site Sofia 1606 Bulgaria Details
GSK Investigational Site Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Guangzhou Guangdong 510080 China Details
GSK Investigational Site Shenzhen Guangdong 518029 China Details
GSK Investigational Site Changsha Jiangsu 221006 China Details
GSK Investigational Site Nanchang Jiangxi 330006 China Details
GSK Investigational Site Changchun Jilin 130012 China Details
GSK Investigational Site Beijing 100000 China Details
GSK Investigational Site Beijing 100050 China Details
GSK Investigational Site Beijing 100191 China Details
GSK Investigational Site Beijing 100730 China Details
GSK Investigational Site Chengdu 610041 China Details
GSK Investigational Site Hangzhou 310009 China Details
GSK Investigational Site Tianjin 300020 China Details
GSK Investigational Site Tianjin 300060 China Details
GSK Investigational Site Zhengzhou 450052 China Details
GSK Investigational Site Le Mans 72015 France Details
GSK Investigational Site Montpellier 34295 France Details
GSK Investigational Site Poitiers cedex 86021 France Details
GSK Investigational Site Tuebingen Baden-Wuerttemberg 72076 Germany Details
GSK Investigational Site Berlin 13125 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Athens 10676 Greece Details
GSK Investigational Site Athens 115 28 Greece Details
GSK Investigational Site Haidari, Athens 12462 Greece Details
GSK Investigational Site Larisa 41 110 Greece Details
GSK Investigational Site Patra 26500 Greece Details
GSK Investigational Site Thessaloniki 54007 Greece Details
GSK Investigational Site Thessaloniki 57010 Greece Details
GSK Investigational Site Budapest 1083 Hungary Details
GSK Investigational Site Budapest 1088 Hungary Details
GSK Investigational Site Budapest 1097 Hungary Details
GSK Investigational Site Debrecen 4012 Hungary Details
GSK Investigational Site Kaposvár 7400 Hungary Details
GSK Investigational Site Nyiregyhaza 4400 Hungary Details
GSK Investigational Site Catanzaro Calabria 88100 Italy Details
GSK Investigational Site Bologna Emilia-Romagna 40138 Italy Details
GSK Investigational Site Ravenna Emilia-Romagna 48123 Italy Details
GSK Investigational Site Roma Lazio 00161 Italy Details
GSK Investigational Site Brescia Lombardia 25123 Italy Details
GSK Investigational Site Milano Lombardia 20141 Italy Details
GSK Investigational Site Pavia Lombardia 27100 Italy Details
GSK Investigational Site San Giovanni Rotondo Puglia 71013 Italy Details
GSK Investigational Site Siena Toscana 53100 Italy Details
GSK Investigational Site Terni Umbria 05100 Italy Details
GSK Investigational Site Milano 20122 Italy Details
GSK Investigational Site Aichi 467-8602 Japan Details
GSK Investigational Site Chiba 277-8567 Japan Details
GSK Investigational Site Ehime 790-8524 Japan Details
GSK Investigational Site Fukushima 960-1295 Japan Details
GSK Investigational Site Gifu 503-8502 Japan Details
GSK Investigational Site Gunma 377-0280 Japan Details
GSK Investigational Site Hokkaido 060-8648 Japan Details
GSK Investigational Site Kyoto 602-8566 Japan Details
GSK Investigational Site Kyoto 603-8151 Japan Details
GSK Investigational Site Osaka 565-0871 Japan Details
GSK Investigational Site Tokyo 108-8639 Japan Details
GSK Investigational Site Tokyo 150-8935 Japan Details
GSK Investigational Site Goyang-si, Gyeonggi-Do 410-769 Korea, Republic of Details
GSK Investigational Site Hwasun 58128 Korea, Republic of Details
GSK Investigational Site Incheon 405-760 Korea, Republic of Details
GSK Investigational Site Seongnam-si, Gyeonggi-do 13620 Korea, Republic of Details
GSK Investigational Site Seoul 03080 Korea, Republic of Details
GSK Investigational Site Seoul 05505 Korea, Republic of Details
GSK Investigational Site Seoul 06591 Korea, Republic of Details
GSK Investigational Site Amersfoort 3813 TZ Netherlands Details
GSK Investigational Site Gdansk 80-952 Poland Details
GSK Investigational Site Krakow 30510 Poland Details
GSK Investigational Site Torun 87-100 Poland Details
GSK Investigational Site Warszawa 02106 Poland Details
GSK Investigational Site Ekaterinburg 620102 Russian Federation Details
GSK Investigational Site Kaluga 248007 Russian Federation Details
GSK Investigational Site Kirov 610027 Russian Federation Details
GSK Investigational Site Krasnoyarsk 660022 Russian Federation Details
GSK Investigational Site Nizhny Novgorod 603137 Russian Federation Details
GSK Investigational Site Novosibirsk 630087 Russian Federation Details
GSK Investigational Site Saint Petersburg 197341 Russian Federation Details
GSK Investigational Site Samara 443021 Russian Federation Details
GSK Investigational Site Sochi 354057 Russian Federation Details
GSK Investigational Site St'Petersburg 191024 Russian Federation Details
GSK Investigational Site Syktyvkar 167904 Russian Federation Details
GSK Investigational Site Tula 300053 Russian Federation Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 08908 Spain Details
GSK Investigational Site Malaga 29004 Spain Details
GSK Investigational Site Pamplona 31008 Spain Details
GSK Investigational Site Pozuelo De Alarcón/Madrid 28223 Spain Details
GSK Investigational Site Salamanca 37007 Spain Details
GSK Investigational Site Santiago de Compostela 15706 Spain Details
GSK Investigational Site Valencia 46017 Spain Details
GSK Investigational Site Airdrie Lanarkshire ML6 0JS United Kingdom Details
GSK Investigational Site Stoke-on-Trent Staffordshire ST4 6QG United Kingdom Details
GSK Investigational Site Dundee DD1 9SY United Kingdom Details
GSK Investigational Site Edinburgh EH4 2XU United Kingdom Details
GSK Investigational Site London EC1 7ED United Kingdom Details
GSK Investigational Site London W12 0NN United Kingdom Details
GSK Investigational Site Nottingham NG5 1PB United Kingdom Details
GSK Investigational Site Oxford OX3 7LJ United Kingdom Details
GSK Investigational Site Plymouth PL6 8D8 United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field